Furthermore, cisplatin-resistant ovarian cancer tissues and cells display increased FOXM1, which therefore acts as an independent indicator of the rapid progression of platinum-resistant epithelial ovarian cancer (EOC); (Tassi et al., 2017). Here, FOXM1 is linked to ovarian carcinoma.